Hers vs Midi Health
Two oral-led services a hundred and twenty dollars apart.
Hers
Editorial
$298/mo
Four GLP-1 lines across two delivery routes, every one of them behind a Hers Weight Loss Membership the site states is required. That membership is $149 a month after a reduced first month, so the compounded semaglutide injection stands at $348 all in. One line carries approved orforglipron rather than a compounded preparation.
Pick it for: Buyers who want the larger brand and accept the rate
Midi Health
Editorial
$178/mo
Four published dose ladders with a milligram figure at every rung, under a page headed for having no membership fee. Injectable semaglutide runs $165.90 to $355.00 and injectable tirzepatide $210.00 to $434.00, with tablet ladders beside them. Every table is labeled a four-week supply rather than a month, so thirteen fills land in a year.
Pick it for: Buyers who want the lower oral figure with the same coverage
Our verdict
Midi Health opens at $178 and Hers at $298 on an oral line, both nationwide, and neither states what happens as the dose rises.
What actually separates them
Hers and Midi Health state different things about published price. Everything else they publish, they publish the same way.
Hers costs $120 more than Midi Health — 67% more for the same molecule. Whether that buys anything is what the rest of this page is for.
Over twelve months that is about $2,136 at Midi Health against $3,576 at Hers — a difference of $1,440.
| Hers | Midi Health | |
|---|---|---|
| Published price | $298/mo | $178/mo |
Before you choose either
Ask both sellers what dose the monthly price buys before you compare the two figures. A price is only a price once you know what quantity it is attached to, and a seller that will not answer has told you something. Set both against every published price we hold rather than against each other alone.
Our take is computed from a published rubric that does not read commercial status, and what is known about safety applies to both of them equally.